Late-stage Resectable Esophageal Squamous Carcinoma
1 clinical trials · Condition
◉ Watch Late-stage Resectable Esophageal Squamous Carcinoma
| Record | Firm | Date |
|---|---|---|
| Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma (NCT07622797) | The First Affiliated Hospital of Henan University of Science and Technology | 2025-11-21 |
Track Late-stage Resectable Esophageal Squamous Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.